A recent report by dunhumby analyzed consumer trust in artificial intelligence. The report found that 46% of consumers believe that security is a valuable use case for AI in the grocery industry.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
